Assessment of predictors of response to DMARD therapies in RA: Real world experience in radius

被引：0
|
作者：
Harrison, MJ
Paulus, HE
Mena, HR
Lipstate, JM
Xia, HA
White, B
机构：
[1] Hosp Special Surg, New York, NY 10021 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA
[3] Baton Rouge Clin, Baton Rouge, LA USA
[4] Amgen Inc, Med Affairs, Thousand Oaks, CA 91320 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2005年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：189 / 189
页数：1
相关论文
共 50 条
  • [21] Real-World Experience of Asciminib: Factors Associated with Response
    Innes, Andrew J.
    Hayden, Chloe
    Orovboni, Victoria
    Rees, David
    Claudiani, Simone
    Fernando, Fiona
    Khan, Afzal
    Byrne, Jennifer
    Gallipoli, Paolo
    Francis, Sebastian
    Copland, Mhairi
    Horne, Gillian
    Raghavan, Manoj
    Arnold, Claire
    Collins, Angela
    Cranfield, Tanya
    Cunningham, Nicholas
    Danga, Akila
    Forsyth, Peter
    Frewin, Rebecca
    Garland, Paula
    Hannah, Guy
    Hassan, Sandra
    Huntly, Brian James Patrick
    Husain, Jissan
    Makkuni, Sudhakaran
    Rothwell, Kate
    Foroni, Letizia
    Apperley, Jane F.
    Milojkovic, Dragana
    [J]. BLOOD, 2022, 140 : 6796 - 6797
  • [22] Real-world Experience with Residential Demand Response Baselines
    Franklin, William W.
    Howerter, Sarah
    Huels, Matthias
    Hines, Paul D. H.
    [J]. 2023 IEEE POWER & ENERGY SOCIETY GENERAL MEETING, PESGM, 2023,
  • [23] Glioma Response to IDH Inhibition: Real-World Experience
    Lukas, Rimas V.
    Horbinski, Craig
    [J]. CLINICAL CANCER RESEARCH, 2023, 29 (23) : 4709 - 4710
  • [24] Real-world effectiveness of select biologic and DMARD monotherapy and combination therapy in the treatment of rheumatoid arthritis: results from the RADIUS observational registry
    Weaver, AL
    Lautzenheiser, RL
    Schiff, MH
    Gibofsky, A
    Perruquet, JL
    Luetkemeyer, J
    Paulus, HE
    Xia, HA
    Leff, JA
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (01) : 185 - 198
  • [25] Daratumumab triplet therapies in patients with relapsed or refractory multiple myeloma: A "real world" experience
    Fucci, Ludovica
    Gensini, Lorenzo
    Coppetelli, Ugo
    La Barbera, Elettra Ortu
    Gentile, Martina
    Fiori, Luciano
    Perrone, Salvatore
    Cimino, Giuseppe
    [J]. LEUKEMIA RESEARCH REPORTS, 2022, 17
  • [26] Predictors of response to anti-CGRP monoclonal antibodies: a scoping review and meta-analysis of real-world experience
    Hong, J. B.
    Lange, K. S.
    Overeem, L. H.
    Triller, P.
    Raffaelli, B.
    Reuter, U.
    [J]. JOURNAL OF HEADACHE AND PAIN, 2024, 25
  • [27] Predictors of galcanezumab response in a real-world study of Korean patients with migraine
    Seung Ae Kim
    Hyemin Jang
    Mi Ji Lee
    [J]. Scientific Reports, 13
  • [28] Ustekinumab in Crohn's disease: real-world outcomes and predictors of response
    Lorenzo Gonzalez, Laura
    Valdes Delgado, Teresa
    Vazquez Moron, Juan Maria
    Castro Laria, Luisa
    Leo Carnerero, Eduardo
    Maldonado Perez, Maria Belen
    Sanchez Capilla, Damian
    Pallares Manrique, Hector
    Saez Diaz, Antonia
    Arguelles Arias, Federico
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2022, 114 (05) : 272 - 279
  • [29] Predictors of galcanezumab response in a real-world study of Korean patients with migraine
    Kim, S.
    Jang, H.
    Lee, M.
    [J]. HEADACHE, 2023, 63 : 154 - 155
  • [30] Predictors of galcanezumab response in a real-world study of Korean patients with migraine
    Kim, Seung Ae
    Jang, Hyemin
    Lee, Mi Ji
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
12345